Volume 28, Issue 3 - Trends in medical writing

The 360° approach to authoring risk management plans

Author: Sushma Materla

Abstract

Download the full article

References

1. ema.europa.eu [Internet]. European Medicines Agency, Risk-management plans, c2017 [cited 2017 Mar 28] Available from: https://www.ema.europa.eu/en/humanregulatory/ marketing-authorisation/ pharmacovigilance/risk-management/riskmanagement- plans.
2. ema.europa.eu [Internet]. European Medicines Agency, Questions and answers on the risk management plan (RMP) summary, c2017 [cited 2017 Mar 30] Available from: https://www.ema.europa. eu/en/documents/other/questionsanswers- risk-management-plan-rmpsummary_ en.pdf.
3. ema.europa.eu [Internet]. European Medicines Agency, Guideline on good pharmacovigilance practices (GVP) Module X – Additional monitoring, c2013 [cited 2013 Apr 19] Available from: https://www.ema.europa.eu/en/documents /scientific-guideline/guideline-goodpharmacovigilance- practices-module-xadditional- monitoring_en.pdf.
4. ec.europa.eu [Internet]. European Commission, Summaries of clinical trial results for laypersons , c2017 [cited 2017 Jan 26] Available from: https://ec.europa.eu/ health/sites/health/files/files/eudralex/vol- 10/2017_01_26_summaries_of_ct_results _for_laypersons.pdf.
5. ema.europa.eu [Internet]. European Medicines Agency, Practical questions and answers to support the implementation of the variations guidelines in the centralised procedure. c2016 [cited 2016 Jun 01]. Available from: https://www.ema.europa. eu/en/documents/regulatory-proceduralguideline/ practical-questions-answerssupport- implementation-variationsguidelines- centralised-procedure_en-0.pdf.